| New Speaker for Companion Diagnostics Event
Austin Tanney, Almac Group, is the latest speaker confirmed for this brand new conference. Austin's talk is titled, 'Development & Commercialisation of Companion Diagnostics from Biomarkers'.
See the full speaker programme here. |
 | |
|
Register for your complimentary delegate place today >>
Submit poster abstracts to posters@elrig.org.
Exhibitor booking >> Ask for details on sponsorships and multiple-booking deals. |
|
Announcing the Launch of our 2nd Next Generation Sequencing Meeting
Every month technological barriers are broken in the field of sequencing. Benefits include the availability of inexpensive and accessible technology for use in a variety of biology/health care research areas as well as in environmental, safety and legal domains. Challenges such as the management, interpretation and beneficial use of the produced data, still remain. However these new breakthroughs provide a clear path forward to sequencing paradigms that will make a huge impact even in everyday life. |
 | |
|
This meeting brings together worldwide experts in the field, with a particular focus on future technologies and applications. The talks will combine provider updates on coming improvements as well as presentations from scientific experts on recent discoveries and applications.
Come and talk to the industry leaders from Illumina and Roche.
Keynote Speaker - Chris Detter, LANL.
Chris is the Group Leader of the Genomics Group at Los Alamos National Laboratory (LANL). The Group primarily focuses on sequencing, finishing and analysis of viral, prokaryotic and eukaryotic genomes. Chris also chairs the organizing committee of Sequencing, Finishing, and Analysis in the Future.
Other speakers so far:
Toby Ost, Pacific Biosciences
Massimiliano Pagani, National Institute of Molecular Genetics.
Register for your complimentary delegate place.
Exhibitor booking here.
Posters - submit your poster entry to posters@elrig.org. | |
|
2012 ELRIG Events
Companion Diagnostics  - from Early Drug Discovery to Clinical Applications
1st May 2012, The Belfry, Oxford
Next Generation Sequencing - Technologies and Future Applications
26th June 2012, Hinxton Hall, Cambridge
Drug Discovery 2012
5th & 6th September 2012, Manchester Central, Manchester
Sessions
1: Assay Development & Screening
2: Fragment Discovery for Enzyme & Membrane Targets
3: Primary Cells & Stem Cells in Discovery
4: Ubiquitinase Drug Discovery
5: Advances in Liquid Handling & Detection Technologies
6: Compound Collection Management & Enhancement
7: Epigenetic Drug Discovery
8: Biophysics & Label Free Detection Technologies
Informatics: Making Knowledge from Laboratory Data - Seminar
Pharmaceutical Flow Cytometry and Imaging
10th & 11th October 2012, AstraZeneca
For further information contact jackie.howard@elrig.org.
|
If you do not wish to receive these emails in future, please let us know |
